- Home
- CSCI vs AEI Comparison
CSCI vs AEI Comparison
Compare CSCI & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSCI
- AEI
- Stock Information
- Founded
- CSCI 1990
- AEI 2014
- Country
- CSCI Canada
- AEI United States
- Employees
- CSCI N/A
- AEI N/A
- Industry
- CSCI
- AEI Building operators
- Sector
- CSCI
- AEI Real Estate
- Exchange
- CSCI NYSE
- AEI Nasdaq
- Market Cap
- CSCI 12.5M
- AEI 13.4M
- IPO Year
- CSCI 1996
- AEI N/A
- Fundamental
- Price
- CSCI $3.70
- AEI $1.55
- Analyst Decision
- CSCI
- AEI
- Analyst Count
- CSCI 0
- AEI 0
- Target Price
- CSCI N/A
- AEI N/A
- AVG Volume (30 Days)
- CSCI 5.3K
- AEI 65.7K
- Earning Date
- CSCI 11-07-2024
- AEI 11-12-2024
- Dividend Yield
- CSCI N/A
- AEI N/A
- EPS Growth
- CSCI N/A
- AEI N/A
- EPS
- CSCI N/A
- AEI N/A
- Revenue
- CSCI $4,915,000.00
- AEI $9,220,976.00
- Revenue This Year
- CSCI N/A
- AEI N/A
- Revenue Next Year
- CSCI N/A
- AEI N/A
- P/E Ratio
- CSCI N/A
- AEI N/A
- Revenue Growth
- CSCI N/A
- AEI N/A
- 52 Week Low
- CSCI $3.49
- AEI $0.46
- 52 Week High
- CSCI $11.10
- AEI $2.05
- Technical
- Relative Strength Index (RSI)
- CSCI N/A
- AEI 60.24
- Support Level
- CSCI N/A
- AEI $1.39
- Resistance Level
- CSCI N/A
- AEI $1.76
- Average True Range (ATR)
- CSCI 0.00
- AEI 0.20
- MACD
- CSCI 0.00
- AEI 0.05
- Stochastic Oscillator
- CSCI 0.00
- AEI 70.74
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.